A conversational interview with Robert Whitfield MD about the challenges of implantable devices, especially in cancer patients. Dr. Whitfield emphasizes heightened infection and explant risk in this population, the need for thorough informed consent, and that implants have variable lifetimes influenced by treatments, exposures, and lifestyle; removal can restore health in some patients.
But I've also had patients who. We've taken it as far as we possibly can, and the only way to overcome it really, is to remove it. And then to watch their health really come back on track is something to behold when that happens. And so I'm just curious, Doc, why that is such a difficult thing for the medical establishment to recognize and own and be willing to support their patients through whether they can find a way to work with it or to lead to removing it.
First of all, anybody who places an implant, especially in a cancer patient, as I did, knows there is a heightened risk for an infection and ultimately an explant. We just didn't sit there. And, you know, I had to go through a long informed consent process when I was doing oncologic reconstruction. And of course, we explained implant factor. So, you know, I. I would say, like, I have the same discussions whether you are a patient getting a reconstruction or a cosmetic patient getting a augmentation and lift or whatever a device goes in. A device has a lifetime. Sometimes it's shorter, sometimes it's longer. Depending on your treatments, exposures, lifestyle, there's all sorts of factors that will affect how that device interacts with your. Your body.
